4//SEC Filing
Adamis Pharmaceuticals Corp 4
Accession 0001387131-16-005710
CIK 0000887247operating
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:50 PM ET
Size
7.7 KB
Accession
0001387131-16-005710
Insider Transaction Report
Form 4
ROTHERMEL ROBERT B
Director
Transactions
- Award
Common Stock
2016-05-25+100,000→ 127,000 total - Award
Employee Stock Option (right to buy)
2016-05-25+30,000→ 30,000 totalExercise: $8.46Exp: 2026-05-25→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock units (RSUs), each one of which represents a contingent right to receive one share of the issuer's common stock. The RSUs vest on the seventh anniversary of the grant date provided that the Reporting Person has continued to provide services to the Company during such period. The RSUs are granted pursuant to the Company's 2009 Equity Incentive Plan and are subject to other provisions as are set forth in the RSU agreement relating to such grant under the plan.
- [F2]The option vests monthly over a period of twelve months commencing on the grant date. The option is granted pursuant to the Company's 2009 Equity Incentive Plan and is subject to other provisions as are set forth in the option agreement relating to such grant under the plan.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000887247
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:50 PM ET
- Size
- 7.7 KB